Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes ... that there’s no longer a shortage of weight-loss drugs that had allowed for alternatives ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention. Now, a ...

Attorney General Dave Sunday is warning Pennsylvanians to make sure they're using licensed pharmacies for GLP-1 drugs amid a growing counterfeit market.

A clinical trial showed that Lilly's weight loss medicine is superior to a key competitor's product. Eli Lilly (NYSE: LLY) is ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Ozempic made headlines. Now its maker faces stock crashes, CEO fallout, and fierce rivalry from Eli Lilly. Discover the trade behind the drama.

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...